Viromed Medical AG

VME

Viromed Medical AG is a medical technology company that develops and markets solutions for air disinfection, wound healing, and intensive care using cold atmospheric plasma technology. The company conducts fundamental research on viruses and bacteria and covers the entire value chain from research and development to production, logistics, marketing, and sales. Its products are applied in hospital air purification, the treatment of chronic wounds and dermatological skin diseases, infected airways, and intensive medicine. Viromed serves a distribution network comprising hospitals, nursing homes, pharmacies, and medical practices. The company has been active in this field since 2004. Summarised from the company's own disclosures, fiscal year ended Oct 2026	Industry Medical Devices	Homepage viromed.de
	Sector Healthcare	IR page viromed.de
	Tags cold plasma, air disinfection, wound healing, intensive care, medical technology, infection control	Press page viromed.de/pressemitteilungen

Metrics

Create a free account Sign in →

Figure	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	5.087M	1.125M	—	—	—
Net profit	—	226.368K	-110.412K	-160.617K	-5.02K

Figure	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Share price	6.05	—	—	—	—

2026-09-28 Vorübergehend nicht erreichbar Bull 0 Bear 0 Not a release

Wir sind schnellstmöglich zurück und bitten in der Zwischenzeit um Ihr Verständnis.

Ihr Viromed-Team

Original on www.viromed.de

Viromed Medical AG (ticker VME), listed in Germany.